Oragenics 뉴스 - OGEN

기업명	주식 심볼	시장	주식 타입
Oragenics Inc	OGEN	AMEX	보통주

	가격 변동	가격 변동 %	주식 가격	최근 거래 시간
	0.00	0.00%	1.02	17:09:42

개장가	저가	고가	종가	전일 종가
				1.02

시세 정보 더보기 »

최근 뉴스

일자	시간	출처	제목
20/04/2024	06:50	BW	Oragenics, Inc. Announces Notification of Noncompliance with..
01/04/2024	22:05	BW	Oragenics, Inc. Files 10K and Provides Company Update
18/03/2024	20:00	BW	Oragenics Appoints James Kelly MD, Chief Medical Officer, to..
07/03/2024	06:24	EDGAR2	Form SC 13G - Statement of acquisition of beneficial..
05/03/2024	21:45	BW	Oragenics, Inc. Prepares Drug for Phase II Clinical Trials..
02/03/2024	06:04	BW	Oragenics Announces Closing of Public Offering
01/03/2024	06:41	EDGAR2	Form 424B5 - Prospectus [Rule 424(b)(5)]
28/02/2024	23:03	EDGAR2	Form 8-K - Current report
28/02/2024	11:25	BW	Oragenics Announces Pricing of Public Offering
28/02/2024	07:09	EDGAR2	Form FWP - Filing under Securities Act Rules 163/433 of free..
28/02/2024	07:04	EDGAR2	Form 424B5 - Prospectus [Rule 424(b)(5)]
28/02/2024	06:33	BW	Oragenics Announces Proposed Public Offering
13/02/2024	10:06	EDGAR2	Form SC 13D - General statement of acquisition of beneficial..
13/02/2024	06:45	EDGAR2	Form 8-K - Current report
13/02/2024	06:41	BW	Oragenics, Inc. Announces Leadership Transition
07/02/2024	22:00	EDGAR2	Form 8-K - Current report
07/02/2024	22:00	BW	Oragenics, Inc. Announces Expiration of Its Investment..
05/02/2024	22:00	EDGAR2	Form 8-K - Current report
05/02/2024	22:00	BW	Oragenics, Inc. Preparing for Phase II Clinical Trials to..
24/01/2024	07:34	BW	Oragenics Announces Termination of At-The-Market Offering..
24/01/2024	07:18	EDGAR2	Form 8-K - Current report
23/01/2024	07:30	EDGAR2	Form 5 - Annual statement of changes in beneficial ownership..
16/01/2024	23:10	EDGAR2	Form 8-K - Current report
16/01/2024	23:08	EDGAR2	Form FWP - Filing under Securities Act Rules 163/433 of free..
16/01/2024	23:04	EDGAR2	Form 424B5 - Prospectus [Rule 424(b)(5)]
11/01/2024	06:37	EDGAR2	Form S-8 - Securities to be offered to employees in employee..
03/01/2024	07:09	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
02/01/2024	23:22	EDGAR2	Form 8-K - Current report
02/01/2024	21:30	BW	Oragenics Completes Acquisition of Odyssey Health’s..
29/12/2023	21:30	EDGAR2	Form 8-K - Current report
16/12/2023	05:45	EDGAR2	Form 8-K - Current report
09/12/2023	06:00	EDGAR2	Form 8-K - Current report
02/12/2023	07:23	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
01/12/2023	07:50	EDGAR2	Form 144 - Report of proposed sale of securities
21/11/2023	05:45	EDGAR2	Form 8-K - Current report
17/11/2023	04:37	EDGAR2	Form DEFA14A - Additional definitive proxy soliciting..
02/11/2023	20:00	EDGAR2	Form 8-K - Current report
02/11/2023	20:00	EDGAR2	Form DEFA14A - Additional definitive proxy soliciting..
02/11/2023	20:00	BW	Oragenics Issues Update to Shareholders
31/10/2023	05:30	EDGAR2	Form DEFA14A - Additional definitive proxy soliciting..
31/10/2023	05:00	EDGAR2	Form DEF 14A - Other definitive proxy statements
18/10/2023	21:30	BW	Oragenics Announces Appointment of Bruce Cassidy and John..
07/10/2023	05:33	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
07/10/2023	05:31	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
07/10/2023	05:28	EDGAR2	Form 3 - Initial statement of beneficial ownership of..
07/10/2023	05:25	EDGAR2	Form 3 - Initial statement of beneficial ownership of..
06/10/2023	06:29	EDGAR2	Form 8-K - Current report
05/10/2023	19:30	EDGAR2	Form 8-K - Current report
05/10/2023	19:30	BW	Oragenics to Acquire Odyssey Health’s Neurological Drug..
30/09/2023	05:00	EDGAR2	Form 8-K - Current report

이 » 주식의 기사 더보기;

시장 데이터

뉴스

도구

시장

팔로우

Hot Features

피드 팔로우

실시간 옵션 플로우

모니터

OGEN Oragenics Inc

최근 뉴스

OGEN 과거 데이터 - 1일

OGEN 과거 데이터 - 1년

최근 히스토리

회사 소개

사업

Popular

앱 받기

시장 데이터

뉴스

도구

시장

팔로우

Hot Features

피드 팔로우

실시간 옵션 플로우

모니터

Oragenics Inc (OGEN) 뉴스

OGEN Oragenics Inc

최근 뉴스

OGEN 과거 데이터 - 1일

OGEN 과거 데이터 - 1년

최근 히스토리

회사 소개

사업

Popular

앱 받기